vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $151.1M, roughly 1.8× STURM RUGER & CO INC). On growth, STURM RUGER & CO INC posted the faster year-over-year revenue change (3.6% vs -16.5%). STURM RUGER & CO INC produced more free cash flow last quarter ($12.3M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.

HCM vs RGR — Head-to-Head

Bigger by revenue
HCM
HCM
1.8× larger
HCM
$270.8M
$151.1M
RGR
Growing faster (revenue YoY)
RGR
RGR
+20.2% gap
RGR
3.6%
-16.5%
HCM
More free cash flow
RGR
RGR
$9.0M more FCF
RGR
$12.3M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
RGR
RGR
Revenue
$270.8M
$151.1M
Net Profit
$2.0M
Gross Margin
37.7%
17.8%
Operating Margin
-13.2%
2.3%
Net Margin
0.7%
Revenue YoY
-16.5%
3.6%
Net Profit YoY
-83.6%
EPS (diluted)
$0.00
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
RGR
RGR
Q4 25
$270.8M
$151.1M
Q3 25
$126.8M
Q2 25
$277.7M
$132.5M
Q1 25
$324.5M
$135.7M
Q4 24
$145.8M
Q3 24
$122.3M
Q2 24
$305.7M
$130.8M
Q1 24
$136.8M
Net Profit
HCM
HCM
RGR
RGR
Q4 25
$2.0M
Q3 25
$1.6M
Q2 25
$455.0M
$-17.2M
Q1 25
$11.9M
$7.8M
Q4 24
Q3 24
$4.7M
Q2 24
$25.8M
$8.3M
Q1 24
$7.1M
Gross Margin
HCM
HCM
RGR
RGR
Q4 25
37.7%
17.8%
Q3 25
15.1%
Q2 25
0.1%
3.9%
Q1 25
48.0%
22.0%
Q4 24
22.8%
Q3 24
18.5%
Q2 24
41.1%
22.3%
Q1 24
21.5%
Operating Margin
HCM
HCM
RGR
RGR
Q4 25
-13.2%
2.3%
Q3 25
-2.7%
Q2 25
-1.3%
-15.6%
Q1 25
-5.0%
6.2%
Q4 24
7.8%
Q3 24
3.1%
Q2 24
-9.0%
6.9%
Q1 24
5.5%
Net Margin
HCM
HCM
RGR
RGR
Q4 25
0.7%
Q3 25
1.2%
Q2 25
163.8%
-13.0%
Q1 25
3.7%
5.7%
Q4 24
Q3 24
3.9%
Q2 24
8.4%
6.3%
Q1 24
5.2%
EPS (diluted)
HCM
HCM
RGR
RGR
Q4 25
$0.00
$0.22
Q3 25
$0.10
Q2 25
$0.52
$-1.05
Q1 25
$0.01
$0.46
Q4 24
$0.62
Q3 24
$0.28
Q2 24
$0.03
$0.47
Q1 24
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
RGR
RGR
Cash + ST InvestmentsLiquidity on hand
$1.4B
$92.5M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$283.8M
Total Assets
$1.8B
$342.0M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
RGR
RGR
Q4 25
$1.4B
$92.5M
Q3 25
$80.8M
Q2 25
$1.4B
$101.4M
Q1 25
$836.1M
$108.3M
Q4 24
$105.5M
Q3 24
$96.0M
Q2 24
$802.5M
$105.6M
Q1 24
$115.3M
Total Debt
HCM
HCM
RGR
RGR
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
RGR
RGR
Q4 25
$1.2B
$283.8M
Q3 25
$279.6M
Q2 25
$1.2B
$289.3M
Q1 25
$759.9M
$321.5M
Q4 24
$319.6M
Q3 24
$314.9M
Q2 24
$740.1M
$321.5M
Q1 24
$332.0M
Total Assets
HCM
HCM
RGR
RGR
Q4 25
$1.8B
$342.0M
Q3 25
$342.3M
Q2 25
$1.8B
$349.5M
Q1 25
$1.3B
$379.0M
Q4 24
$384.0M
Q3 24
$373.5M
Q2 24
$1.3B
$376.7M
Q1 24
$385.0M
Debt / Equity
HCM
HCM
RGR
RGR
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
RGR
RGR
Operating Cash FlowLast quarter
$8.2M
$15.5M
Free Cash FlowOCF − Capex
$3.4M
$12.3M
FCF MarginFCF / Revenue
1.2%
8.2%
Capex IntensityCapex / Revenue
1.8%
2.1%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$38.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
RGR
RGR
Q4 25
$8.2M
$15.5M
Q3 25
$12.9M
Q2 25
$-72.9M
$14.7M
Q1 25
$40.3M
$11.1M
Q4 24
$20.0M
Q3 24
$9.4M
Q2 24
$-39.8M
$18.7M
Q1 24
$7.3M
Free Cash Flow
HCM
HCM
RGR
RGR
Q4 25
$3.4M
$12.3M
Q3 25
$7.0M
Q2 25
$-82.2M
$9.1M
Q1 25
$32.5M
$10.0M
Q4 24
$16.4M
Q3 24
$2.6M
Q2 24
$-49.9M
$10.1M
Q1 24
$5.6M
FCF Margin
HCM
HCM
RGR
RGR
Q4 25
1.2%
8.2%
Q3 25
5.5%
Q2 25
-29.6%
6.9%
Q1 25
10.0%
7.4%
Q4 24
11.2%
Q3 24
2.1%
Q2 24
-16.3%
7.7%
Q1 24
4.1%
Capex Intensity
HCM
HCM
RGR
RGR
Q4 25
1.8%
2.1%
Q3 25
4.6%
Q2 25
3.3%
4.2%
Q1 25
2.4%
0.8%
Q4 24
2.5%
Q3 24
5.5%
Q2 24
3.3%
6.6%
Q1 24
1.3%
Cash Conversion
HCM
HCM
RGR
RGR
Q4 25
4.21×
Q3 25
8.15×
Q2 25
-0.16×
Q1 25
3.38×
1.43×
Q4 24
Q3 24
1.98×
Q2 24
-1.54×
2.27×
Q1 24
1.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

RGR
RGR

Firearms$150.6M100%
Castings$7.3M5%

Related Comparisons